Topic: Humans

Journal: Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

Documents

A list of abstracts that contain a topic of "Humans" and a journal name of "Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology".

• Phase Ii Trial of Intravesical Gemcitabine in Bacille Calmette-guérin-refractory Transitional Cell Carcinoma of the Bladder.

  PMID: 16782913

• American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer.

  PMID: 17159189

• Phase Iii Trial of Intraperitoneal Therapy with Yttrium-90-labeled Hmfg1 Murine Monoclonal Antibody in Patients with Epithelial Ovarian Cancer After a Surgically Defined Complete Remission.

  PMID: 16446329

• Pharmacokinetics of Gemcitabine in Japanese Cancer Patients: the Impact of a Cytidine Deaminase Polymorphism.

  PMID: 17194903

• New Muc1 Serum Immunoassay Differentiates Pancreatic Cancer from Pancreatitis.

  PMID: 16344318

• Monitoring the Physical Health of Cancer Survivors: a Survivorship-focused Medical History.

  PMID: 17093271

• Postradiotherapy Neck Dissection for Lymph Node-positive Head and Neck Cancer: the Use of Computed Tomography to Manage the Neck.

  PMID: 16549836

• Early Response Evaluation in Malignant Pleural Mesothelioma by Positron Emission Tomography with [18f]fluorodeoxyglucose.

  PMID: 17008700

• Impact of Complete Response to Chemotherapy on Overall Survival in Advanced Colorectal Cancer: Results from Intergroup N9741.

  PMID: 17687151

• Superficial and Muscle-invasive Bladder Cancer: Principles of Management for Outcomes Assessments.

  PMID: 17158537

• Managing Older Patients with Colorectal Cancer.

  PMID: 17488988

• Novel Prognostic Immunohistochemical Biomarker Panel for Estrogen Receptor-positive Breast Cancer.

  PMID: 16809728

• Multicenter Phase Ii Study of Irinotecan, Cisplatin, and Bevacizumab in Patients with Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma.

  PMID: 17114652

• Low Value of [18f]-fluoro-2-deoxy-d-glucose Positron Emission Tomography in Primary Staging of Early-stage Cervical Cancer Before Radical Hysterectomy.

  PMID: 16382121

• Extranodal Natural Killer T-cell Lymphoma, Nasal-type: a Prognostic Model from a Retrospective Multicenter Study.

  PMID: 16380410

• Association of High-level Mrp1 Expression with Poor Clinical Outcome in a Large Prospective Study of Primary Neuroblastoma.

  PMID: 16575006

• Multicenter Validation of a Gene Expression-based Prognostic Signature in Lymph Node-negative Primary Breast Cancer.

  PMID: 16505412

• Survival Improvement in Patients with Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti-carcinoembryonic-antigen Radioimmunotherapy: a Collaborative Study with the French Endocrine Tumor Group.

  PMID: 16549819

• Mortality After Major Surgery for Urologic Cancers in Specialized Urology Hospitals: Are They Any Better?

  PMID: 16648501

• Effect of Chest X-rays on the Risk of Breast Cancer Among Brca1/2 Mutation Carriers in the International Brca1/2 Carrier Cohort Study: a Report from the Embrace, Genepso, Geo-hebon, and Ibccs Collaborators' Group.

  PMID: 16801631

• Effects of Cognitive Behavior Therapy in Severely Fatigued Disease-free Cancer Patients Compared with Patients Waiting for Cognitive Behavior Therapy: a Randomized Controlled Trial.

  PMID: 17050873

• Attitudes and Practices of Breast Cancer Consultations Regarding Sexual Issues: a Nationwide Survey of Japanese Surgeons.

  PMID: 17179110

• Correlation of Computed Tomography and Positron Emission Tomography in Patients with Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution with Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria.

  PMID: 17470865

• Breast Cancer in the Elderly.

  PMID: 17488987

• Phase I/Ii Trial of Erlotinib and Cisplatin in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: a Princess Margaret Hospital Phase Ii Consortium and National Cancer Institute of Canada Clinical Trials Group Study.

  PMID: 17538162

• Educating Undergraduate Medical Students About Oncology: a Literature Review.

  PMID: 16622269

• Late Relapses of Germ Cell Malignancies: Incidence, Management, and Prognosis.

  PMID: 17158535

• Phase Iii Study of Capecitabine Plus Oxaliplatin Compared with Fluorouracil and Leucovorin Plus Oxaliplatin in Metastatic Colorectal Cancer: a Final Report of the Aio Colorectal Study Group.

  PMID: 17548840

• Role and Relevance of Neurocognitive Assessment in Clinical Trials of Patients with Cns Tumors.

  PMID: 16525186

• Use of Modeling to Evaluate the Cost-effectiveness of Cancer Screening Programs.

  PMID: 17210941

• Radiation Therapy and the Geriatric Oncology Patient.

  PMID: 17488993

• Activity of Su11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-derived Growth Factor Receptor, in Patients with Metastatic Renal Cell Carcinoma.

  PMID: 16330672

• Diagnosis and Treatment of Recurrent High-grade Astrocytoma.

  PMID: 16525182

• Mechanisms of Hypertension Associated with Bay 43-9006.

  PMID: 16446323

• Phase Ii Study of Capecitabine, Oxaliplatin, and Erlotinib in Previously Treated Patients with Metastastic Colorectal Cancer.

  PMID: 16622264

• Phase Ii Multicenter Study of Neoadjuvant Biochemotherapy for Patients with Stage Iii Malignant Melanoma.

  PMID: 16809738

• Dynamic Contrast-enhanced Magnetic Resonance Imaging As an Imaging Biomarker.

  PMID: 16829653

• Complete Response of Colorectal Liver Metastases After Chemotherapy: Does It Mean Cure?

  PMID: 16921046

• Randomized Phase Iii Trial of Gemcitabine Plus Cisplatin Compared with Gemcitabine Alone in Advanced Pancreatic Cancer.

  PMID: 16921047

• Immunohistochemical Detection Using the New Rabbit Monoclonal Antibody Sp1 of Estrogen Receptor in Breast Cancer is Superior to Mouse Monoclonal Antibody 1d5 in Predicting Survival.

  PMID: 17116944

• Phase I/Ii Study of Continuous-infusion Troxacitabine in Refractory Acute Myeloid Leukemia.

  PMID: 17146106

• Regression After Whole-brain Radiation Therapy for Brain Metastases Correlates with Survival and Improved Neurocognitive Function.

  PMID: 17401015

• Phase I Pharmacokinetic and Biologic Correlative Study of Mapatumumab, a Fully Human Monoclonal Antibody with Agonist Activity to Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptor-1.

  PMID: 17416859

• Suffering with Advanced Cancer.

  PMID: 17470861

• Tumor Thymidylate Synthase 1494del6 Genotype As a Prognostic Factor in Colorectal Cancer Patients Receiving Fluorouracil-based Adjuvant Treatment.

  PMID: 16575011

• Prognostic Significance of 99mtc Hynic-rh-annexin V Scintigraphy During Platinum-based Chemotherapy in Advanced Lung Cancer.

  PMID: 17577031

• Enhancing Radiotherapy with Genetically Engineered Viruses.

  PMID: 17827458

• Management of Venous Thromboembolism in Patients with Primary and Metastatic Brain Tumors.

  PMID: 16525187

• Prognostic Factors for Stage Iii Epithelial Ovarian Cancer: a Gynecologic Oncology Group Study.

  PMID: 17704411

• Impact of the Year 2000 Medicare Policy Change on Older Patient Enrollment to Cancer Clinical Trials.

  PMID: 16330670

• Phase Ii Study of Clofarabine in Pediatric Patients with Refractory or Relapsed Acute Lymphoblastic Leukemia.

  PMID: 16622268

• Multicenter Phase Ii Trial of Immunotherapy with the Humanized Anti-cd22 Antibody, Epratuzumab, in Combination with Rituximab, in Refractory or Recurrent Non-hodgkin's Lymphoma.

  PMID: 16864854

• Development of Neuropathy in Patients with Myeloma Treated with Thalidomide: Patterns of Occurrence and the Role of Electrophysiologic Monitoring.

  PMID: 16940275

• Gene Expression Profiling Reveals Reproducible Human Lung Adenocarcinoma Subtypes in Multiple Independent Patient Cohorts.

  PMID: 17075127

• Quantification of Regulatory T Cells Enables the Identification of High-risk Breast Cancer Patients and Those at Risk of Late Relapse.

  PMID: 17135638

• Peritumoral Fibroblast Sparc Expression and Patient Outcome with Resectable Pancreatic Adenocarcinoma.

  PMID: 17235047

• Melanoma in Children and Teenagers: an Analysis of Patients from the National Cancer Data Base.

  PMID: 17416855

• Phase Iii Study of Erlotinib in Combination with Cisplatin and Gemcitabine in Advanced Non-small-cell Lung Cancer: the Tarceva Lung Cancer Investigation Trial.

  PMID: 17442998

• American Society of Clinical Oncology 2007 Clinical Practice Guideline Update on the Role of Bisphosphonates in Multiple Myeloma.

  PMID: 17515569

• Tumor Necrosis Factor Alpha As a New Target for Renal Cell Carcinoma: Two Sequential Phase Ii Trials of Infliximab at Standard and High Dose.

  PMID: 17925549

• Phase Ii Study of Neoadjuvant Docetaxel, Vinorelbine, and Trastuzumab Followed by Surgery and Adjuvant Doxorubicin Plus Cyclophosphamide in Women with Human Epidermal Growth Factor Receptor 2-overexpressing Locally Advanced Breast Cancer.

  PMID: 17296975

• Increased Toxicity with Gefitinib, Capecitabine, and Radiation Therapy in Pancreatic and Rectal Cancer: Phase I Trial Results.

  PMID: 16446337

• Short-term Treatment-related Symptoms and Quality of Life: Results from an International Randomized Phase Iii Study of Cisplatin with or Without Raltitrexed in Patients with Malignant Pleural Mesothelioma: an Eortc Lung-cancer Group and National Cancer Institute, Canada, Intergroup Study.

  PMID: 16446322

• Detection of Occult Lymph Node Metastases in Locally Advanced Node-negative Prostate Cancer.

  PMID: 16782914

• Progression-free Survival Rate As Primary End Point for Phase Ii Cancer Clinical Trials: Application to Mesothelioma--the Eortc Lung Cancer Group.

  PMID: 16809726

• Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 Mrna-positive Cells Detected by Real-time Polymerase Chain Reaction in Node-negative Breast Cancer Patients.

  PMID: 16769987

• Overcoming Resistance to Interferon-induced Apoptosis of Renal Carcinoma and Melanoma Cells by Dna Demethylation.

  PMID: 16801630

• Phase Iii Trial Comparing Supportive Care Alone with Supportive Care with Oral Topotecan in Patients with Relapsed Small-cell Lung Cancer.

  PMID: 17135646

• Outcome After Radiotherapy Alone for Metastatic Spinal Cord Compression in Patients with Oligometastases.

  PMID: 17194905

• Health-related Quality of Life in Younger Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine Plus Cyclophosphamide or Fludarabine Alone for First-line Therapy: a Study by the German Cll Study Group.

  PMID: 17389338

• Identifying Stage Iii Colorectal Cancer Patients: the Influence of the Patient, Surgeon, and Pathologist.

  PMID: 17577036

• A Nomogram Predicting 10-year Life Expectancy in Candidates for Radical Prostatectomy or Radiotherapy for Prostate Cancer.

  PMID: 17704404

• Identification of Patients with Prostate Cancer Who Benefit from Immediate Postoperative Radiotherapy: Eortc 22911.

  PMID: 17878474

• Randomized Phase Ii Study of Erlotinib Combined with Bevacizumab Compared with Bevacizumab Alone in Metastatic Renal Cell Cancer.

  PMID: 17876014

• Tumor Transcriptome Reveals the Predictive and Prognostic Impact of Lysosomal Protease Inhibitors in Non-small-cell Lung Cancer.

  PMID: 16549823

• High-dose Chemotherapy with Autologous Stem-cell Transplantation and Hyperfractionated Radiotherapy As First-line Treatment of Primary Cns Lymphoma.

  PMID: 16864853

• Plasma Cytokine and Soluble Receptor Signature Predicts Outcome of Patients with Classical Hodgkin's Lymphoma: a Study from the Groupe D'etude Des Lymphomes De L'adulte.

  PMID: 17389336

• Noninvasive Evaluation of Late Anthracycline Cardiac Toxicity in Childhood Cancer Survivors.

  PMID: 17704413

• Randomized Comparison of Every-2-week Darbepoetin Alfa and Weekly Epoetin Alfa for the Treatment of Chemotherapy-induced Anemia: the 20030125 Study Group Trial.

  PMID: 16710026

• Phase Ii Placebo-controlled Randomized Discontinuation Trial of Sorafenib in Patients with Metastatic Renal Cell Carcinoma.

  PMID: 16636341

• 11c-acetate Positron Emission Tomography Imaging and Image Fusion with Computed Tomography and Magnetic Resonance Imaging in Patients with Recurrent Prostate Cancer.

  PMID: 16636343

• Health-related Quality of Life Measurement in Randomized Clinical Trials in Surgical Oncology.

  PMID: 16809741

• Comparison of Orally Administered Cannabis Extract and Delta-9-tetrahydrocannabinol in Treating Patients with Cancer-related Anorexia-cachexia Syndrome: a Multicenter, Phase Iii, Randomized, Double-blind, Placebo-controlled Clinical Trial from the Cannabis-in-cachexia-study-group.

  PMID: 16849753

• Identification of Angiogenesis/Metastases Genes Predicting Chemoradiotherapy Response in Patients with Laryngopharyngeal Carcinoma.

  PMID: 17416856

• Late Effects of Cancer and Hematopoietic Stem-cell Transplantation on Spouses or Partners Compared with Survivors and Survivor-matched Controls.

  PMID: 17416860

• Bevacizumab in Combination with Oxaliplatin, Fluorouracil, and Leucovorin (Folfox4) for Previously Treated Metastatic Colorectal Cancer: Results from the Eastern Cooperative Oncology Group Study E3200.

  PMID: 17442997

• Economic Analysis of Ncic Ctg Jbr.10: a Randomized Trial of Adjuvant Vinorelbine Plus Cisplatin Compared with Observation in Early Stage Non-small-cell Lung Cancer--a Report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials Group.

  PMID: 17538170

• Long-term Follow-up of a Randomized Trial Comparing Concurrent Single Agent Cisplatin, Cisplatin-based Combination Chemotherapy, or Hydroxyurea During Pelvic Irradiation for Locally Advanced Cervical Cancer: a Gynecologic Oncology Group Study.

  PMID: 17502627

• Biologic and Clinical Characteristics of Breast Cancer with Single Hormone Receptor Positive Phenotype.

  PMID: 17876012

• Randomized Phase Iii Study of Trastuzumab, Paclitaxel, and Carboplatin Compared with Trastuzumab and Paclitaxel in Women with Her-2-overexpressing Metastatic Breast Cancer.

  PMID: 16782917

• Phase I Trial of Oral Fenretinide in Children with High-risk Solid Tumors: a Report from the Children's Oncology Group (Ccg 09709).

  PMID: 16849757

---